Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
clinical trials
4
×
fda
life sciences
national blog main
national top stories
new york top stories
novartis
4
×
amgen
boston blog main
boston top stories
national
new york blog main
san francisco top stories
biogen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
gene therapy
genentech
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
zolgensma
10x genomics
abbvie
alder biopharmaceuticals
alirocumab
What
fda
4
×
drug
new
medicines
won
acquire
agreed
amgen
approval
approved
atrophy
august
billion
bio
biotech
brings
busy
candidates
cash
cholesterol
class
company
compound
daily
days
deal
decisions
developed
devices
drugs
evrysdi
friday
gets
green
head
home
intended
legacy
lights
liquid
Language
unset
Current search:
biotech
×
novartis
×
" clinical trials "
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
